1381 – 1390 of 1515
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
- Contribution to journal › Article
-
Mark
Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
- Contribution to journal › Article
-
Mark
EVOLUTION OF A beta 42 AND A beta 40 LEVELS AND A beta 42/A beta 40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Long-term rivastigmine treatment in a routine clinical setting.
- Contribution to journal › Article
-
Mark
Neurodegenerative Biomarkers in Healthy Elderly - with special reference to the preclinical pattern of biological and cognitive markers for Alzheimer’s disease
- Thesis › Doctoral thesis (compilation)
-
Mark
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- Contribution to journal › Article
-
Mark
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
- Contribution to journal › Article
-
Mark
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
- Contribution to journal › Article
-
Mark
Concentrations of Metals, beta-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
- Contribution to journal › Article
